USE OR ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMID ACID MATRIX METALLOPROTEINASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF TOXEMIA

Details for Australian Patent Application No. 2003253346 (hide)

Owner NOVARTIS AG

Inventors CULVER, Kenneth, Wayne

Pub. Number AU-A-2003253346

PCT Number PCT/EP03/08316

PCT Pub. Number WO2004/012737

Priority 60/399,291 29.07.02 US

Filing date 28 July 2003

Wipo publication date 23 February 2004

International Classifications

A61K 031/4406 - only substituted in position 3, e.g. zimeldine

A61P 043/00 Drugs for specific purposes, not provided for in groups

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 60/399,291 29.07.02 US

1 April 2004 Application Open to Public Inspection

  Published as AU-A-2003253346

28 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003253347-BRAKE SERVO UNIT COMPRISING AN EMERGENCY BRAKE AUXILIARY FUNCTION

2003253345-IMPEDANCE MEASUREMENT IN A FLUIDIC MICROSYSTEM